US Stock MarketDetailed Quotes

MDT Medtronic

Watchlist
  • 86.540
  • +0.270+0.31%
Close Nov 29 13:00 ET
  • 86.940
  • +0.400+0.46%
Post 17:01 ET
110.97BMarket Cap26.46P/E (TTM)

About Medtronic Company

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Company Profile

SymbolMDT
Company NameMedtronic
Listing DateNov 21, 1977
Founded2014
CEOMr. Geoffrey S. Martha
MarketNYSE
Employees95000
Fiscal Year Ends04-25
AddressParkmore Business Park West,Building Two
CityGalway
ProvinceGA
CountryIreland
Zip Code2
Phone353-1-438-1700

Company Executives

  • Name
  • Position
  • Salary
  • Geoffrey S. Martha
  • Chief Executive Officer and Chairman of the Board
  • 20.08M
  • Gary Corona
  • Interim Chief Financial Officer
  • --
  • Jennifer M. Kirk
  • Senior Vice President, Global Controller and Chief Accounting Officer
  • --
  • Michael Marinaro
  • Executive Vice President and President, Medical Surgical Portfolio and Surgical Operating Unit
  • --
  • Gregory L. Smith
  • Executive Vice President, Global Operations and Supply Chain
  • 7.66M
  • Brett A. Wall
  • Executive Vice President and President, Neuroscience Portfolio
  • 6.44M
  • Sean M. Salmon
  • Executive Vice President and President, Cardiovascular Portfolio
  • 6.55M
  • Ivan K. Fong
  • Executive Vice President, General Counsel and Corporate Secretary
  • --
  • Kendall J. Powell
  • Independent Director
  • 350.06K
  • Gregory P. Lewis
  • Independent Director
  • 306.97K
  • Lidia L. Fonseca
  • Independent Director
  • 350.06K
  • Kevin E. Lofton
  • Independent Director
  • 370.06K
  • Craig Arnold
  • Lead Independent Director
  • 410.06K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 370.06K
  • Scott C. Donnelly
  • Independent Director
  • 365.06K
  • Randall J. Hogan, III
  • Independent Director
  • 385.06K
  • Dr. Andrea J. Goldsmith, PhD
  • Independent Director
  • 370.06K
  • Denise M. O'Leary
  • Independent Director
  • 375.06K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data